Zhang Shuangqing | cognition | Best Researcher Award

Posted on by Cognitive Scientist Awards

Prof. Zhang Shuangqing | cognition | Best Researcher Award

Dr. Shuang-Qing Zhang is a distinguished professor at the Department of Nutrition and Metabolism, National Institute for Nutrition and Health, Chinese CDC, Beijing. With a robust academic background in pharmaceutics and over two decades of research experience, he has significantly contributed to the fields of pharmacokinetics, nutritional toxicology, and functional food safety. His global expertise is enriched through international collaborations, notably as a visiting senior fellow at the National University of Singapore and postdoctoral research in the USA. Dr. Zhang is a prolific author with numerous high-impact publications and is a respected editor across 20+ international journals. His research interests span selenium and cognitive function, nanoparticle drug delivery, and health food safety evaluation. He actively serves on multiple scientific committees and advisory boards in China. Through his innovative projects and policy-informing studies, Dr. Zhang continues to shape national nutrition, drug safety, and public health discourse.

Profile

🎓 Education

Dr. Shuang-Qing Zhang holds a Ph.D. in Pharmaceutics from Peking University (2002–2005), after earning both B.S. and M.S. degrees in Pharmaceutics from Shenyang Pharmaceutical University (1995–2002). His academic foundation was solidified through extensive training in drug formulation, pharmacokinetics, and pharmaceutical sciences. He further advanced his expertise as a postdoctoral researcher at the University of Mississippi and Texas Tech University (2005–2008), focusing on drug metabolism and toxicokinetics. In 2013–2014, he served as a Visiting Senior Research Fellow at the Yong Loo Lin School of Medicine, National University of Singapore, where he explored translational nutrition research. This diverse and international academic training underpins his authoritative voice in pharmaceutics, toxicology, and nutrition science, and continues to inform his interdisciplinary research on health food safety, pharmacodynamics, and nanomedicine.

đŸ§Ș Experience

Dr. Zhang began his professional journey as a postdoctoral researcher in the United States before returning to China as an Associate Professor at the National Institutes for Food and Drug Control (2010–2012), specializing in drug metabolism and safety. Since 2012, he has been a Professor at the Chinese CDC’s Department of Nutrition and Metabolism, leading pioneering work in nutritional toxicology, pharmacokinetics, and health food evaluation. He serves as an expert evaluator for China’s major scientific funding and regulatory agencies, including the National Natural Science Foundation and Ministry of Science and Technology. Dr. Zhang also plays advisory roles in national health committees related to environmental mutagens and food safety. His dedication extends to editorial duties for over 20 journals and authorship of influential monographs in toxicology and nutriomics. He actively mentors scholars, oversees major research grants, and contributes to national policy development in food and drug safety.

🏅 Awards and Honors

Dr. Zhang has earned national recognition through prestigious funding awards such as the National Natural Science Foundation of China, Scientific Research Foundation for Returned Overseas Chinese Scholars, and multiple provincial and national-level research programs. His leadership in interdisciplinary projects addressing osteoporosis, cancer drug development, and nanoparticle therapeutics has positioned him as a trusted advisor to government science bodies. In 2015 and 2019, he was a recipient of the National Publication Foundation Support for his authored books on nutriomics and medical foods. As an editorial board member and guest editor for numerous international scientific journals, Dr. Zhang has been honored for his editorial leadership and influence in the scientific publishing community. He is a Distinguished Professor at the Chinese Academy of Agricultural Sciences and a standing or core member of several scientific committees across nutrition, toxicology, pharmacology, and food science sectors.

🔬 Research Focus

Dr. Zhang’s research encompasses nutritional pharmacology, drug metabolism, toxicokinetics, and functional food safety. He is internationally recognized for his studies on selenium’s role in cognitive function, publishing extensively on selenium intake, pharmacokinetics, and its neuroprotective effects in aging populations. His lab investigates nanoparticle-based drug delivery systems, targeting conditions like postmenopausal osteoporosis and cancer, with a focus on osteoblast-specific biomimetic designs. Another focal point is the pharmacodynamics of poly(L-glutamic acid)-paclitaxel conjugates, offering solutions to multi-drug resistance. Dr. Zhang also leads efforts in evaluating the safety and bioavailability of functional foods, including selenium-, zinc-, and chromium-enriched yeasts, using advanced techniques like UPLC-MS/MS and ion chromatography. His interdisciplinary research integrates toxicology, nutrition, and pharmaceutical science to bridge clinical translation and public health applications, while also informing regulatory policy on dietary intake thresholds and novel drug safety assessments in China and beyond.

✅ Conclusion

Dr. Shuang-Qing Zhang is a globally respected professor and scientist whose impactful research on nutritional pharmacology, selenium neurobiology, and nanomedicine has significantly advanced food and drug safety, earning him national recognition, global collaborations, and editorial leadership.

Publications

1. Bai YZ, Gao YX, Zhang SQ*. Identification of factors on blood selenium levels
in the US adults: a cross-sectional study. Nutrients, 2024, 16(11): e1734.
2. Bai YZ, Zhang SQ*. Selenium intake is an effective strategy for the
improvement of cognitive decline in low cognition older Americans. Int J Food
Sci Nutr. 2024, 75(7): 687-694. (* corresponding author)
3. Bai YZ, Li JM, Zhang SQ*. A nonlinear association between total selenium
intake and blood selenium concentration: an analysis based on the National
Health and Nutrition Examination Survey 2011-2018. J Food Sci. 2024,
89(12): 9955-9967. (* corresponding author)
4. Li JM, Bai YZ, Liu QY, Zhang SQ*. Mediation effect of oxidative stress on the
association between selenium intake and cognition in American adults.
Nutrients, 2024, 16(23): e4163. (* corresponding author)

 

 

 

 

Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Posted on by Cognitive Scientist Awards

Assos. Prof. Dr. Konrad Talbot | Alzheimer’s Disease | Best Researcher Award

Dr. Konrad Talbot is a distinguished neuroscientist and Associate Professor at Loma Linda University School of Medicine, serving in the Departments of Neurosurgery, Pathology & Human Anatomy, and Basic Sciences since 2018. He specializes in investigating the pathogenesis and treatment of neurodegenerative and psychiatric disorders, particularly focusing on brain insulin resistance in Alzheimer’s and Parkinson’s diseases. With a Ph.D. in Physiological Psychology from UCLA and extensive postdoctoral training at the University of Pennsylvania, Dr. Talbot has held faculty and research positions at leading institutions such as Cedars-Sinai, UCLA, and UPenn. He is a highly cited researcher (H-index: 34, 9341 citations), with significant NIH and international grant support. He also serves as an editorial board member, reviewer, and invited speaker at global conferences. His work has influenced both fundamental neuroscience and the development of therapeutic strategies for brain diseases.

Profile

🎓 Education

Dr. Konrad Talbot completed his undergraduate (B.A.), master’s (M.A.), and doctoral (Ph.D.) degrees in Psychology with a specialization in Physiological Psychology at the University of California, Los Angeles (UCLA). His academic path reflects a deep commitment to understanding the biological underpinnings of behavior and brain function. He also received formal teaching certification from UCLA’s Instructor Development Program in 1992. His postdoctoral training included pivotal roles at the University of Pennsylvania’s Department of Pathology and Laboratory Medicine and the Center for Neurodegenerative Disease Research (1997–2001), where he developed expertise in brain autopsy and pathology. He furthered his technical capabilities through advanced training in quantitative fluorescence microscopy at Mount Desert Island Biological Laboratory in 2007. His broad educational background forms a strong foundation for his interdisciplinary research and teaching roles across psychology, neurobiology, pathology, and medical sciences.

đŸ§Ș Experience

Dr. Talbot’s academic journey spans over three decades, beginning as an Assistant Professor at Mount St. Mary’s College and St. Olaf College, where he taught psychology and mentored numerous students. He transitioned into intensive research roles at the University of Pennsylvania (UPenn) from 1997 to 2012, ascending from postdoctoral investigator to senior research investigator and research faculty. He later held associate research professorships at Cedars-Sinai Medical Center and UCLA. Since 2018, he has served as Associate Professor at Loma Linda University. Dr. Talbot has authored influential studies on brain insulin resistance, taught neuroanatomy to medical residents, supervised postdoctoral and undergraduate research projects, and served in various academic leadership and committee roles. In addition to his research and teaching, he has contributed editorial expertise to high-impact journals and consulted on landmark neuroanatomical atlases. His career reflects a blend of teaching excellence, pioneering research, and interdisciplinary leadership.

🏅 Awards and Honors

Dr. Talbot’s contributions have been widely recognized through prestigious awards and honors. In 2003, he received the T.L.L. Temple Foundation Discovery Award from the Alzheimer’s Association for his groundbreaking work on brain insulin resistance. He was honored as a co-dedicatee of the influential neuroscience text The Mouse Brain in Stereotaxic Coordinates (2008 edition), highlighting his impact on anatomical brain mapping. In 2020, he was inducted into the Sigma Chi Scientific Research Honor Society. His professional affiliations include long-standing memberships with the Society for Neuroscience, Alzheimer Research Forum, Schizophrenia Research Forum, and ISTAART (International Society to Advance Alzheimer Research and Treatment). He has played leadership roles in organizing major scientific conferences, chaired institutional committees, and served on advisory panels. His editorial contributions and invited lectures worldwide further underscore the scientific community’s high regard for his research excellence and thought leadership.

🔬 Research Focus

Dr. Talbot’s research centers on identifying and targeting mechanisms underlying neurodegenerative and psychiatric diseases, with a special emphasis on insulin resistance in the brain. He has pioneered investigations showing that brain insulin resistance plays a critical role in Alzheimer’s and Parkinson’s disease pathogenesis. His NIH-funded work explores the therapeutic potential of incretin receptor agonists—an emerging class of antidiabetics—in reducing brain insulin resistance and improving cognitive function. His collaborative projects with institutions like CUNY, UCLA, and the University of Washington focus on both human brain tissue analysis and preclinical models. Past research includes the molecular biology of schizophrenia, especially dysbindin-related pathways. He holds a U.S. patent application on methods for treating brain insulin resistance, signaling the translational potential of his findings. Dr. Talbot’s research integrates neuropharmacology, pathology, neuroanatomy, and clinical neuroscience, aiming to develop disease-modifying treatments that can halt or reverse progression in cognitive and psychiatric disorders.

✅ Conclusion

Dr. Konrad Talbot is an accomplished neuroscientist whose multidisciplinary work in brain insulin resistance has significantly advanced understanding and treatment approaches for Alzheimer’s and Parkinson’s diseases, blending rigorous research, impactful teaching, and translational innovation.

Publications

Crhistiane Andressa da Silva | Chronobiology and Memory | Neurocognitive Breakthrough Award

Posted on by Cognitive Scientist Awards

Dr. Crhistiane Andressa da Silva | Chronobiology and Memory | Neurocognitive Breakthrough Award

 

EstĂșdio Amanhecer, Brazil

Profile

Education

She earned her Doctorate in Psychology from the Universidade Federal do Rio Grande do Norte (UFRN), Natal, Brazil, in 2012, with a Sandwich Doctorate at the Universitat de Barcelona under the supervision of Antoni Díez-Noguera. Her doctoral research, titled SAGUIS (Callithrix jacchus) SOB CICLO CLARO-ESCURO DE 21 H: UM MODELO DE DESSINCRONIZAÇÃO FORÇADA EM PRIMATA DIURNO, was conducted under the guidance of John Fontenele Araujo, with Carolina Virgínia Macedo de Azevedo as a co-advisor. She received a scholarship from the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.

She completed her Master’s in Pharmacology at UFRN in 2007, with a thesis titled EFEITOS DE VOCALIZAÇÕES DE CO-ESPECÍFICOS E DO ESCURO SOBRE O RITMO CIRCADIANO DA ATIVIDADE MOTORA EM SAGÜIS (Callithrix jacchus), under the supervision of Carolina VirgĂ­nia MacĂȘdo de Azevedo. Her research was supported by a CAPES scholarship.

She earned her Bachelor’s degree in Biological Sciences from UFRN in 2003, with a thesis titled Perfil DiĂĄrio do Comportamento de Autocatação Durante Um Ciclo Ovariano em DĂ­ades de Saguis (Callithrix jacchus), under the supervision of Carolina VirgĂ­nia MacĂȘdo de Azevedo. She received a scholarship from the Conselho Nacional de Desenvolvimento CientĂ­fico e TecnolĂłgico (CNPq), Brazil.

Work experience

She worked as a Postdoctoral Researcher at the Universidade Federal da ParaĂ­ba (UFPB) from 2014 to 2017 under a full-time and exclusive contract. She then continued her postdoctoral research at the Universidade Federal de Pernambuco (UFPE) from 2017 to 2018 under the same work scheme.

In 2018, she served as a part-time Professor at Faculdade Escritor Osman da Costa Lins (FACOL), where she taught the course PrĂĄticas Integrativas Complementares em SaĂșde for the Physiotherapy program.

Since 2021, she has been the owner and full-time instructor at EstĂșdio Amanhecer, where she teaches yoga.

Areas of Expertise

She specializes in Public Health within the broader field of Health Sciences, as well as Physiology and General Biology within Biological Sciences. Her expertise also extends to Zoology, with a focus on Animal Behavior.

Scientific, Technological & Academic Production

She has contributed to bibliographic research and publications in her fields of study.

Citations

Her research has been cited in various academic databases:

  • Web of Science: 44 citations across 3 articles (as of June 2, 2024), with an H-index of 3.
  • Google Scholar: 26 citations across 9 articles (as of January 17, 2017).

The citation search included variations of her name: Silva, C.A.; da Silva, C.A.; CA da Silva; CA Silva; C da Silva, Crhistiane Andressa da Silva; Christiane Andressa da Silva; da Silva, Christiane Andressa; da Silva, Crhistiane Andressa

Awards & Recognitions

  • 2023 & 2024: TOP MASTER GOLD award by popular vote, recognized as a distinguished professional in her field in Rio Grande do Norte for her contributions to local development.
  • 2022: Named Best Yoga Teacher of 2022 in Natal and awarded Best of the Year in Natal.
  • 2017: Secured second place in the Banner category on the theme Chronobiology at the IX Symposium of Psychobiology.

Publication